中国肥胖代谢外科数据库：2024年度报告

doi:10.3877/cma.j.issn.2095-9605.2025.02.001

目的

统计分析2024年中国肥胖代谢外科手术开展情况。

方法

基于中国肥胖代谢外科数据库，通过多源数据交叉验证综合推算手术数量、术式分布及从业人员规模等。本次统计未含中国香港、中国澳门及中国台湾地区的数据。

结果

来自中国大陆29个省（自治区、直辖市），75个城市，共190家医院纳入本次统计。综合推算全国减重手术总数量为32 342例，开展减重手术的医院为970家，减重外科医生为1 430位，减重个案管理师为800位。数量最多的三种手术方式依次为袖状胃切除术（SG，24 443例，75.6%）、Roux-en-Y胃旁路术（RYGB，1 520例，4.7%）、单吻合口胃旁路术（OAGB，1 234例，3.8%），死亡4例（0.017%）。

结论

全国减重手术量较前一年稍有下降（下降13.2%），本年度数量最多的三种手术方式依次为SG、RYGB及OAGB。肥胖代谢外科应借力"体重管理年"活动，发展体重管理多学科协同的综合诊疗体系，加强规范化培训、多中心临床研究及国际交流合作，推动学科的健康发展，提升诊疗水平及国际影响力。

关键词: 减重手术, 代谢手术, 数据库, 年度报告, 死亡率, 个案管理

Objective

To analyze the status and number of metabolic and bariatric surgeries (MBS) in China in 2024.

Methods

Surgical volumes, procedure distribution, and workforce scale were estimated through integrated synthesis with multi-source data cross-validation, based on the Chinese Obesity and Metabolic Surgery Database (COMES Database). This study did not include data from the Hong Kong SAR, Macao SAR, and Taiwan region of China.

Results

190 hospitals were included in this study, covering 29 provinces (autonomous regions and municipalities) and 75 cities, with a total estimated 32 342 cases. It was also estimated that there were 970 hospitals in the country, with 1 430 bariatric surgeons and 800 case managers involved in MBS. The top three most performed MBS were sleeve gastrectomy (SG, 24 443 cases, 75.6%), Roux-en-Y gastric bypass (RYGB, 1 250 cases, 4.7%), one-anastomosis gastric bypass (OAGB, 1 234 cases, 3.8%), and 4 (0.017%) deaths reported.

Conclusions

The number of MBS decreased by 13.2% in 2024. The most performed procedures were SG, RYGB and OAGB. We should leverage the national "Weight Management Year" initiative to develop an integrated multidisciplinary care system for weight management. This requires strengthening standardized training programs, promoting multicenter clinical research, and enhancing international collaborations. Such efforts will advance the discipline’s sustainable development, elevate clinical standards, and expand its global standing.

Key words: Bariatric surgery, Metabolic surgery, Database, Annual report, Mortality, Case management

图1 2008-2024年中国肥胖代谢外科手术推算数量趋势图^[2,3,4,5,6]注：RYGB：Roux-en-Y gastric bypass，Roux-en-Y胃旁路术；OAGB：One-anastomosis gastric bypass，单吻合口胃旁路术；SG：Sleeve gastrectomy，袖状胃切除术；SG Plus：袖状胃切除联合手术；AGB：Adjustable gastric banding，可调节胃束带术；Fundoplication：胃底折叠术；JIB/GIA：Jejunoileal bypass/gastric-ileal anastomosis，空肠回肠旁路术/(大胃囊)胃肠吻合术；DS/SADI-S：Duodenal switch/Single-anastomosis duodenoileal bypass with sleeve gastrectomy，十二指肠转位术/单吻合口十二指肠回肠旁路术联合袖状胃切除术；Endoscopic：内镜减重手术/技术；Revision：修正手术；Other：其他；TOTAL：总数

表1 2008-2024年中国肥胖代谢外科手术推算数量^[2,3,4,5,6]

术式	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	%
RYGB	10	30	395	850	1 660	3 132	2 920	2 350	1 830	1 729	2 380	1 851	976	1 505	1 117	901	1 520	4.7
SG	10	30	60	165	240	777	2 200	3 221	4 201	5 119	6 233	7 386	10 669	19 846	25 642	30 352	24 443	75.6
OAGB	0	0	0	0	0	0	0	0	0	0	0	75	100	537	760	1228	1234	3.8
SG Plus	0	0	0	0	0	48	30	110	49	15	560	646	1064	1999	1618	2183	3021	9.3
AGB	97	220	185	135	45	36	0	1	0	0	0	0	7	1	1	0	5	0.0
Fundoplication	0	0	0	0	5	113	90	10	32	10	5	0	30	103	11	254	112	0.3
JIB/GIA	0	0	0	0	0	0	0	400	100	1 880	1 200	1 500	850	581	650	1 718	801	2.5
DS/SADI-S	0	0	0	0	0	0	0	0	0	0	0	10	145	311	6	99	102	0.3
Endoscopic	0	0	0	0	0	0	0	0	0	0	0	9	12	58	15	21	158	0.5
Revision	0	0	0	0	0	0	0	0	100	110	120	134	182	237	248	385	725	2.2
Other	0	0	0	0	0	0	0	0	28	79	77	89	2	30	3	108	221	0.7
TOTAL	117	280	640	1 150	1 950	4 106	5 240	6 092	6 340	8 942	10 575	11 700	14 037	25 208	30 071	37 249	32 342	100.0

表1 2008-2024年中国肥胖代谢外科手术推算数量^[2,3,4,5,6]

术式	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	%
RYGB	10	30	395	850	1 660	3 132	2 920	2 350	1 830	1 729	2 380	1 851	976	1 505	1 117	901	1 520	4.7
SG	10	30	60	165	240	777	2 200	3 221	4 201	5 119	6 233	7 386	10 669	19 846	25 642	30 352	24 443	75.6
OAGB	0	0	0	0	0	0	0	0	0	0	0	75	100	537	760	1228	1234	3.8
SG Plus	0	0	0	0	0	48	30	110	49	15	560	646	1064	1999	1618	2183	3021	9.3
AGB	97	220	185	135	45	36	0	1	0	0	0	0	7	1	1	0	5	0.0
Fundoplication	0	0	0	0	5	113	90	10	32	10	5	0	30	103	11	254	112	0.3
JIB/GIA	0	0	0	0	0	0	0	400	100	1 880	1 200	1 500	850	581	650	1 718	801	2.5
DS/SADI-S	0	0	0	0	0	0	0	0	0	0	0	10	145	311	6	99	102	0.3
Endoscopic	0	0	0	0	0	0	0	0	0	0	0	9	12	58	15	21	158	0.5
Revision	0	0	0	0	0	0	0	0	100	110	120	134	182	237	248	385	725	2.2
Other	0	0	0	0	0	0	0	0	28	79	77	89	2	30	3	108	221	0.7
TOTAL	117	280	640	1 150	1 950	4 106	5 240	6 092	6 340	8 942	10 575	11 700	14 037	25 208	30 071	37 249	32 342	100.0

[1]	NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults [J]. Lancet, 2024, 403(10431): 1027-1050.
[2]	杨华, 陈缘, 王存川, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2019年度报告 [J/OL]. 中华肥胖与代谢病电子杂志, 2020, 6(3): 143-149.
[3]	杨华, 陈缘, 董志勇, 等. 中国肥胖代谢外科数据库: 2020年度报告 [J/OL]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 1-7.
[4]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2021年度报告 [J/OL]. 中华肥胖与代谢病电子杂志. 2022, 8(1): 15-23.
[5]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2022年度报告 [J/OL]. 中华肥胖与代谢病电子杂志, 2023, 9(2): 83-91.
[6]	中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2023年度报告 [J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(2): 73-83.
[7]	Lin K, Mehrotra A, Tsai TC. Metabolic bariatric surgery in the era of GLP-1 receptor agonists for obesity management [J]. JAMA Network Open, 2024, 7(10): e2441380.
[8]	Tang S, Yu S, Wang C, et al. Factors Influence the acceptance of surgical treatment in chinese bariatric surgery candidates [J]. Obes Surg, 2018, 28(9): 2767-2773.
[9]	Fan M, Hong J, Cheung PN, Tang S, Zhang J, Hu S, et al. Knowledge and Attitudes Towards Obesity and Bariatric Surgery in Chinese Nurses [J]. Obes Surg, 2020, 30(2): 618-629.
[10]	Diao X, Gao L, Yang Y, et al. Knowledge and attitudes towards obesity and bariatric surgery in university students: a national survey [J]. Obes Surg, 2022, 32(9): 2869-2879.
[11]	Xiao N, Ding Y, Cui B, et al. Navigating obesity: A comprehensive review of epidemiology, pathophysiology, complications and management strategies [J]. The Innovation Medicine, 2024, 2(3): 100090.
[12]	Jensen SBK, Blond MB, Sandsdal RM, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial [J]. EclinicalMedicine, 2024, 69: 102475.
[13]	Brown A, Sergent H, Vu AH, et al. Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study [J]. Surg Endosc, 2025, Online ahead of print.
[14]	Çalık Başaran N, Dotan I, Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels [J]. International Journal of Obesity, 2025, 49(3): 412-417.
[15]	Shin TH, Medhati P, Mathur V, et al. National trends in using revisional surgeries post-sleeve gastrectomy due to reflux and weight recurrence: a matched case-control analysis [J]. Surg Obes Relat Dis, 2025, 21(3): 240-246.
[16]	Liagre A, Martini F, Van Haverbeke O, et al. Ten-year outcomes of sleeve gastrectomy in a single-center series of 156 patients: weight loss and need of revisional surgery [J]. Am J Surg, 2025, 248: 116525.
[17]	国家卫生健康委办公厅. 国家卫生健康委办公厅关于禁止将"空肠回肠吻合术"应用于2型糖尿病治疗的通知 [EB/OL]. (2025-06-28) [2025-07-08]. URL
[18]	Au K, Zheng MH, Lee WJ, et al. Resmetirom and metabolic dysfunction-associated steatohepatitis: perspectives on multidisciplinary management from global healthcare professionals [J]. Curr Obes Rep, 2024, 13(4): 818-830.
[19]	Clyde DR, Adib R, Baig S, et al. An international Delphi consensus on patient preparation for metabolic and bariatric surgery [J]. Clin Obes, 2025, 15(2): e12722.
[20]	Yang W, Abbott S, Borg CM, et al. Global variations in preoperative practices concerning patients seeking primary bariatric and metabolic surgery (PACT Study): A survey of 634 bariatric healthcare professionals [J]. Int J Obes (Lond), 2022, 46(7): 1341-1350.

[1]	皮颖, 张强, 黄志荣. 80 岁以上股骨颈骨折患者术后1 年死亡率的预测因素[J/OL]. 中华关节外科杂志(电子版), 2025, 19(01): 13-20.
[2]	张卿, 张长青, 黄轶刚. 全球股髋撞击综合征临床研究注册信息的分析与思考[J/OL]. 中华关节外科杂志(电子版), 2025, 19(01): 27-33.
[3]	程呈, 卢帅, 陈蓉, 李新萍, 白睿峰, 崔更力, 陈烁, 殷家伟, 胡建鹏, 汪垚卓, 蒋协远, 陈海翎. 基于基因表达数据库分析非酒精性脂肪性肝病炎症损伤相关核心基因[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(02): 99-106.
[4]	中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识（2024 版）[J/OL]. 中华普通外科学文献(电子版), 2025, 19(01): 1-8.
[5]	陈斌雄, 谢铭. 袖状胃切除术与胃旁路术对肥胖合并T2DM的治疗效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 461-466.
[6]	张鹏, 史慢慢, 马辉, 吴佼佼, 赵暾, 张颖彬. 急性呼吸窘迫综合征患者机械通气动脉血二氧化碳分压变异率与预后风险相关性[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(02): 226-230.
[7]	李菲, 郭晓夏, 郑悦, 郑爔, 李鑫成, 李文雄. 他汀类药物对甘油三酯葡萄糖指数增高的脓毒症相关急性肾损伤患者预后的影响[J/OL]. 中华肾病研究电子杂志, 2025, 14(02): 68-76.
[8]	包良笑, 刘兆锋, 谢豪, 杨钦烽, 史占军. 美国住院患者膝关节翻修术后肺部并发症发病率及危险因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(01): 4-13.
[9]	吴振帼, 于岩波, 李延青. 内镜减重与代谢疗法的治疗新进展[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(03): 193-198.
[10]	陈莎莎, 李捷, 李飞, 方臻飞, 潘文志, 周达新, 吴永健, 葛均波. 2024年经导管主动脉瓣置换术年度报告[J/OL]. 中华心脏与心律电子杂志, 2025, 13(02): 65-72.
[11]	潘良彬, 王南, 马海涛, 谢凯. 肺癌偏侧性与第二肺癌的预后：基于SEER数据库的回顾性研究[J/OL]. 中华胸部外科电子杂志, 2025, 12(02): 66-82.
[12]	张睿旻, 朱红梅, 刘雁军. 中国肥胖代谢外科临床研究现状及展望：一项计量学研究[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 1-10.
[13]	王文博, 曹耀权, 朱利勇. 新型减重药物的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 19-25.
[14]	李梦蝶, 王勇. 替西帕肽在优化减重代谢手术中的作用展望[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 26-32.
[15]	张畅, 周昆明, 黄桢雅, 孙鸿儒, 蔺宏伟. 符合脐解剖的经脐横行小切口在单孔腹腔镜减重手术中的应用[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 46-52.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Chinese Obesity and Metabolic Surgery Database: Annual Report 2024

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Chinese Obesity and Metabolic Surgery Database: Annual Report 2024